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Abstract
Objective:  To  analyze  the  development  and  prevalence  of  gastrointestinal  signs  and  symptoms
associated  with  the  development  of  the  digestive  tract,  and  to  assess  the  measures  aimed  to
reduce their  negative  impacts.
Source  of  data:  Considering  the  scope  and  comprehensiveness  of  the  subject,  a  systematic
review of  the  literature  was  not  carried  out.  The  Medline  database  was  used  to  identify  refer-
ences that  would  allow  the  analysis  of  the  study  topics.
Synthesis  of  results:  Infants  frequently  show  several  gastrointestinal  signs  and  symptoms.
These clinical  manifestations  can  be  part  of  gastrointestinal  functional  disorders  such  as  infan-
tile colic,  infant  regurgitation,  and  functional  constipation.  Allergy  to  cow’s  milk  protein  and
gastroesophageal  reﬂux  disease  are  also  causes  of  these  clinical  manifestations  and  represent
an important  and  difﬁcult  differential  diagnosis.  The  diseases  that  course  with  gastrointestinal
signs and  symptoms  can  have  an  impact  on  family  dynamics  and  maternal  emotional  status,
and may  be  associated  with  future  problems  in  the  child’s  life.  Comprehensive  pediatric  care
is essential  for  diagnosis  and  treatment.  Maternal  breastfeeding  should  always  be  maintained.
Some special  formulas  can  contribute  to  the  control  of  clinical  manifestations  depending  on  the
established  diagnosis.
Conclusion:  During  the  normal  development  of  the  digestive  tract,  several  gastrointestinal  signs
and symptoms  may  occur,  usually  resulting  from  functional  gastrointestinal  disorders,  gastro-
esophageal  reﬂux  disease,  and  allergy  to  cow’s  milk  protein.  Breastfeeding  should  always  be
maintained.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Sinais  e  sintomas  associados  com  o  desenvolvimento  do  trato  digestivo
Resumo
Objetivo:  Analisar  o  desenvolvimento  e  a  prevalência  de  sinais  e  sintomas  gastrintestinais
associados  com  o  desenvolvimento  do  tubo  digestivo  e  as  medidas  que  visam  diminuir  suas
repercussões  negativas.
Fontes  dos  dados:  Considerando  a  abrangência  e  amplitude  do  tema,  não  foi  realizada  revisão
sistemática da  literatura.  Utilizou-se  a  base  de  dados  do  Medline  para  a  identiﬁcac¸ão  de  refer-
ências bibliográﬁcas  que  permitissem  contemplar  os  temas  de  estudo.
Síntese  dos  resultados:  O  lactente  apresenta  com  elevada  frequência  vários  sinais  e  sintomas
gastrintestinais.  Estas  manifestac¸ões  clínicas  podem  fazer  parte  de  distúrbios  funcionais  gastrin-
testinais  como  a  cólica  do  lactente,  regurgitac¸ão  do  lactente  e  constipac¸ão  intestinal  funcional.
A alergia  à  proteína  do  leite  de  vaca  e  doenc¸a  do  reﬂuxo  gastroesofágico  também  são  causas
destas manifestac¸ões  clínicas  e  representam  um  importante  e  difícil  diagnóstico  diferencial.  As
doenc¸as que  cursam  com  sintomas  e  sinais  gastrintestinais  podem  ter  consequências  na  dinâmica
familiar e  no  estado  emocional  das  mães.  Podem  se  associar  com  problemas  na  vida  futura  da
crianc¸a. A  atenc¸ão  pediátrica  completa  é  fundamental  para  o  diagnóstico  e  o  tratamento.  O
aleitamento  natural  deve  sempre  ser  mantido.  Algumas  fórmulas  especiais  podem  contribuir
para o  controle  das  manifestac¸ões  clínicas  na  dependência  do  diagnóstico  estabelecido.
Conclusão:  Durante  o  desenvolvimento  normal  do  tubo  digestivo  podem  ocorrer  vários  sinais
e sintomas  gastrintestinais  em  geral  decorrentes  dos  distúrbios  gastrintestinais  funcionais,  da
doenc¸a do  reﬂuxo  gastroesofágico  e  da  alergia  à  proteína  do  leite  de  vaca.  Aleitamento  natural
deve sempre  ser  mantido.
©  2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Since  the  conception,  characterized  by  the  moment  when
the  sperm  enters  the  egg,  the  biological  potential  for  the
formation  of  a  new  human  being  develops  into  a  fascinat-
ing  process  of  cell  multiplication  and  differentiation.  The
maturation  of  the  individual  occurs  during  the  course  of
different  stages  of  life.  Currently,  the  ﬁrst  1000  days,  start-
ing  at  conception,  are  considered  to  be  a  critical  period
to  deﬁne  the  health  status  of  the  individual  and  can  have
consequences  throughout  life.1,2
The  ﬁrst  two  years  of  life  are  an  important  part  of  this
period,  which  is  characterized  by  accelerated  growth  rate
and  development  of  several  organs  and  systems.  There-
fore,  gastrointestinal  signs  and  symptoms  can  occur  in
infants,3,4 which  may  be  linked  to  several  anatomical  and
functional  changes  observed  at  this  stage  of  life.  In  addition
to  these  clinical  manifestations,  there  may  be  repercussions
in  the  individual’s  future,5 as  well  as  consequences  that
will  interfere  in  family  dynamics  and  the  parents’  emotional
status.
It  can  be  said  that  the  development  of  the  digestive
system  comprises  not  only  the  anatomical  and  functional
aspects  of  its  organs  but  also  local  and  systemic  interactions
with  the  intestinal  immune  system  and  the  establishment
of  the  gastrointestinal  microbiota.  The  interaction  among
these  three  processes  has  been  the  object  of  many  basic
science  and  clinical  studies  searching  for  alternatives  that
can  provide  favorable  results  during  the  ﬁrst  1000  days  and
several  future  cycles  of  life.
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lThis  article  aimed  to  analyze  the  emergence  and  preva-
ence  of  gastrointestinal  signs  and  symptoms  associated  with
he  development  of  the  gastrointestinal  tract  and  measures
imed  to  reduce  their  negative  impacts.
ethods
onsidering  the  scope  and  comprehensiveness  of  the  sub-
ect,  a  systematic  review  of  the  literature  was  not  carried
ut.  The  Medline  database  was  used  to  identify  literature
eferences  that  included  the  subject  of  the  study.  Among
thers,  were  used  the  following  terms  in  the  search  for  infor-
ation,  ‘‘digestive,’’  ‘‘tract,’’  ‘‘ontogeny,’’  ‘‘microbiota,’’
‘development,’’  ‘‘premature,’’  ‘‘oral,’’  and  ‘‘tolerance’’.
hen  necessary,  the  research  was  restricted  to  humans.
he  author  also  used  his  personal  experience  and  trends
iscussed  in  national  and  international  scientiﬁc  events.
natomical  and  functional  development  of  the
astrointestinal  tract
he  intestine  is  one  of  the  most  complex  organs  in  the  human
ody,  both  from  the  anatomical  and  functional  point  of  view.
he  intestinal  cells  and  tissues  are  formed  from  all  three
erm  layers.  Intestinal  stem  cells  derive  from  the  meso-
erm,  the  muscle  tissue  of  the  endoderm,  and  the  enteric
ervous  system  of  the  ectoderm.6 In  addition  to  the  diges-
ive  and  absorptive  functions,  there  are  also  the  intestinal
ndocrine  system  (involved  in  the  regulation  of  systemic
evels  of  nutrients  and  feeding  behavior)  and  the  so-called
S48  Morais  MB
Table  1  Main  milestones  of  intestinal  development7
Time  of  gestation
Cell  differentiation
Development  of  intestinal  segments  10th  week  of  gestation
Fixation  of  the  angle  of  Treitz  and  rectum  12th  week  of  gestation
Development  of  crypts  and  villi From  the  9th  to  the  20th  week  of  gestation
Apoptosis of  villous  epithelial  cells 18th  week  of  gestation
Digestion
Development  receptors  for  vitamin  B12
absorption  along  the  entire  intestine  with
exclusive  activity  in  the  terminal  ileum  at  the
end  of  gestation
From  the  6th  to  the  30th  week  of  gestation
Detection of  peptidase,  sucrase,  lactase,
insulin,  glucagon,  IGF-1,  cholecystokinin,  and
secretin  activity
From  the  9th  up  to  the  12th  week  of  gestation
70% of  sucrase  activity  34th  week  of  gestation
Maximum  lactase  activity  Only  on  the  40th  week  of  gestation
Colon loses  the  crypt/villus  structure  and  of
sucrase  and  aminopeptidase  activity
After  the  36th  week
Increased  gastric  lipase  activity  After  the  24th  week
Absorption
Sodium-dependent  glucose  transporter  1
(SGLT1)
After  the  17th  week.  Lower  capacity  at  birth  in  relation  to
infant  and  adult
Glucose transport  in  the  basolateral  membrane Presence  of  GLUT-2  between  the  17th  and  30th  weeks
Motility
Deglutition Of  amniotic  ﬂuid  after  the  20th  week
Enterocolonic  motility  Disorganized  after  the  24th  week  of  gestation.  Propagation
of migratory  motor  complex  between  the  33rd  and  the  36th
weeks.  Maturation  of  interdigestive  motility  after  the  36th
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bntestinal  barrier,  which  prevents  the  passage  of  the  intesti-
al  contents,  including  microorganisms,  into  the  body.
The  epithelial  function  is  carried  out  by  four  types  of
ells:  enterocytes,  which  are  responsible  for  absorption,
nd  three  types  of  secretory  cells  (mucus-producing  gob-
et  cells,  antibacterial  substance-producing  Paneth  cells,
nd  several  enteroendocrine  cells  that  regulate  satiety,
ntestinal  absorption,  proliferation  of  pancreas  -cells,  and
ormone  secretion,  among  others).6 It  is  also  noteworthy  the
ntense  epithelial  proliferation  of  stem  cells,  which  renew
he  luminal  surface  of  the  intestine  in  a  few  days,  and  the
omplex  interaction  among  the  epithelium,  smooth  muscle,
nd  enteric  nervous  system,  to  ensure  a  unidirectional  ﬂow
rovided  by  intestinal  peristalsis.6
The  development  of  the  intestine  during  gestation  can  be
ivided  into  four  basic  processes:  1.  cell  differentiation;  2.
igestion;  3.  absorption;  and  4.  motility.7 Table  1  shows  the
ajor  milestones  of  intestinal  development.7
These  physiological  properties  are  very  important  to
nderstand  the  feeding  process  of  the  newborn,  especially
hose  preterm.  The  transition  from  parenteral  feeding  via
he  umbilical  cord  and  small  amounts  of  swallowed  amniotic
uid  to  obtaining  complete  nutrients  from  the  colostrum
nd  breast  milk  occurs  at  birth.7 At  that  time,  the  intestine
ndergoes  a  rapid  morphological  growth  process  in  terms
f  length  and  absorptive  surface.  It  is  noteworthy  that  the
ntestinal  length  is  estimated  at  50  cm  in  the  middle  of
h
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Tweek
regnancy,  at  approximately  100  cm  in  the  weeks  before
irth,  and  200  cm  in  the  ﬁrst  weeks  of  life.7 The  colostrum
timulus  is  important  in  this  process.7
Preterm  infant  feeding  is  a  major  challenge  due  to  the
mmaturity  of  the  digestive  system  (especially  of  the  swal-
owing  reﬂex),  the  lower  lactase  activity,  and  the  immature
attern  of  the  gastrointestinal  tract  motility.  These  facts
xplain,  at  least  in  part,  the  high  prevalence  of  food  intoler-
nce,  gastroesophageal  reﬂux,  and  constipation  in  preterm
nfants.7
olonization  of  the  digestive  tract
he  development  of  molecular  biology  techniques,  which
o  not  depend  on  bacterial  isolation  through  conventional
ulture  methods,  has  led  to  extraordinary  increase  in  the
nowledge  of  microorganisms  that  live  in  the  intestine.8
ore  than  1013 microorganisms  can  be  found  per  gram  of
ntestinal  contents  in  the  colon.  Knowledge  about  bacte-
ial  diversity  has  also  increased  since  the  identiﬁcation
f  new  species  that  comprise  the  digestive  tract  micro-
iota.  It  is  believed  that  the  number  of  genes  in  the
uman  microbiota  is  100  times  higher  than  in  the  human
ody.  It  is  noteworthy  that  there  is  a  mutual  and  ben-
ﬁcial  interaction  between  the  microbiota  and  the  host.
hus,  there  are  not  only  nutritional  interactions  (colonic
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fermentation  with  the  production  of  short-chain  fatty  acids
that  are  absorbed  in  the  colon,  and  lipid  and  protein
hydrolysis)  but  also  interaction  with  the  intestinal  immune
system.1,8
It  should  be  remembered  that  the  intestinal  microbiota
is  not  constituted  only  of  bacteria.  Fungi  and  viruses  are
also  found  in  the  lumen  of  the  gastrointestinal  tract.  The
potential  therapeutic  use  of  viruses  interfering  with  the
intestinal  microbiota  composition  represents  a  new  chal-
lenge  in  research  on  the  microbiome  of  humans.9
The  belief  that  the  fetus  lives  in  a  sterile  environment
has  been  modiﬁed  in  recent  years  based  on  evidence  of  the
existence  of  microorganisms  in  the  amniotic  ﬂuid,  umbili-
cal  cord  blood,  fetal  membranes,  and  the  placenta.10 These
ﬁndings  should  be  interpreted  with  caution  due  to  the  pos-
sibility  of  contamination  of  the  samples  at  the  time  of
collection.10 The  changes  in  the  mother’s  vaginal  and  colonic
microbiota  during  pregnancy  are  noteworthy,  considering
that  the  maternal  microbiota  inﬂuences  the  formation  of
the  fetus’  and  the  newborn’s  microbiota.10
On  the  ﬁrst  day  of  life  there  is  fast  newborn  intesti-
nal  colonization  by  microorganisms  from  the  maternal
and  environmental  microbiota.8 The  ﬁrst  colonizing  agents
belong  to  the  genera  Escherichia  and  Enterococcus. Sub-
sequently,  anaerobic  bacteria  of  the  Biﬁdobacterium  and
Bacteroidetes  genera  appear.  That  is,  the  ﬁrst  bacteria
are  facultative  anaerobic  (Staphylococcus,  Streptococcus,
Enterococcus,  Enterobacter) that  contribute  to  the  devel-
opment  of  an  anaerobic  environment  in  the  intestine,  which
thus  allows  the  for  colonization  by  obligate  anaerobes  (Biﬁ-
dobacterium,  Bacteriodetes, Clostridium, Eubacterium).1
With  the  introduction  of  complementary  foods  to
breast  milk  in  the  infant’s  diet  an  important  impact  is
observed  on  the  intestinal  microﬂora,  characterized  by
decreased  participation  of  biﬁdobacteria  (which,  how-
ever,  remains  predominant)  and  increased  diversity  with
greater  participation  of  bacteria  from  the  genera  Bac-
teroides  and  Clostridium.1 A  study  performed  with  Brazilian
infants  receiving  exclusive  breastfeeding  identiﬁed  six
phyla  in  the  fecal  microbiota:  Bacteroidetes,  Firmi-
cutes,  Fusobacterium,  Proteobacteria,  Actinobacteria,  and
Verrucomicrobia.11 At  three  months  of  life,  there  was  a  pre-
dominance  of  Streptococcus  and  Escherichia; at  six  months,
the  predominance  of  Escherichia  was  observed.11
The  colonization  of  the  digestive  tract  of  the  newborn
and  infant  depends  on  several  factors,  especially  the  type
of  delivery  and  type  of  feeding.  Over  the  ﬁrst  two  years  of
life,  it  is  observed  that  the  caesarean  delivery  is  associated
with  greater  abundance  of  Firmicutes  and  lower  of  Bac-
teroidetes.  During  the  ﬁrst  six  months  of  life  it  is  observed
that  the  colonization  by  Bacteroidetes  occurs  at  a  later
phase.  At  the  end  of  two  years  of  life,  the  relative  abun-
dance  of  microbial  constituents  is  similar  in  both  infants
born  by  vaginal  delivery  and  caesarean  section.  It  was  also
observed  that  the  circulating  levels  of  cytokines  produced  by
helper  T  lymphocytes  are  lower  among  those  born  through
caesarean  section.  It  should  be  noted  that  the  fecal  micro-
biota  of  mothers  of  children  born  through  caesarean  section
and  vaginal  delivery  were  not  different.12
Regarding  the  type  of  feeding,  it  is  well  known  that  the
intestinal  microbiota  of  infants  who  are  exclusively  breast-
fed  is  different  from  those  fed  with  artiﬁcial  formula.13--15
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reast  milk  is  rich  in  oligosaccharides  that  inﬂuence  the
omposition  of  the  intestinal  microbiota.16,17 It  is  also  known
hat  the  oligosaccharide  proﬁle  in  breast  milk  is  not  the
ame  in  all  mothers.18,19 The  speciﬁc  effects  of  these
ifferent  oligosaccharide  proﬁles  on  the  intestinal  micro-
iota  are  not  yet  fully  known.18,19 However,  breast  milk
as  considered  practically  sterile  until  some  years  ago.
ecently  a  hypothesis  was  raised  that  suggests  a new  way
f  communication  between  the  mother’s  and  the  infant’s
icrobiota.20,21 In  this  context,  it  is  suggested  that  bacte-
ia  from  the  mother’s  intestinal  microbiota  would  reach  the
reast  milk  by  translocation  from  the  intestinal  lumen  and
hrough  bloodstream  transportation,  featuring  an  internal
nteromammary  pathway.20,21 This  hypothesis  was  created
ased  on  animal  studies.  These  bacteria  could  inﬂuence  the
nfant’s  colonization  process  and  maturation  of  the  immune
ystem.  Another  possible  pathway  is  the  entry  of  bacteria
rom  the  skin  tissue  of  the  mother  in  the  mammary  gland
hrough  the  nipple.20,21 Thus,  colostrum  and  human  milk  are
ot  only  sources  of  oligosaccharides  that  stimulate  the  for-
ation  of  intestinal  microﬂora  but  also  probably  a  source  of
acteria  for  the  infant.  It  is  estimated  that  800  mL  of  breast
ilk  can  contain  up  to  105 to  107 colony-forming  units.  The
acteria  that  have  been  identiﬁed  in  breast  milk  samples
elong  mainly  to  the  genera  Lactobacillus, Staphylococcus,
nterococcus,  and  Biﬁdobacterium.20,21
The  intestinal  microbiota,  through  molecular  structures
hat  constitute  the  microbe-associated  molecular  patterns
MAMPs)  interacts  with  the  intestinal  immunological  sys-
em  and  the  intestinal  barrier  and  also  interferes  with  the
roduction  of  mucus.  They  stimulate  cell  proliferation  in
he  crypts  and  Paneth  cells  responsible  for  producing  the
ntimicrobial  peptides  called  defensins.  This  interaction
‘‘crosstalk’’)  occurs  with  speciﬁc  receptors,  such  as  the
oll-like  receptors.  Pro-inﬂammatory  responses  can  be  neu-
ralized  by  the  specialized  regulatory  T  (Treg)  cells  through
nterleukin  10  production.
This  mechanism  is  very  important  in  the  development
f  oral  tolerance.  Probiotic  bacteria  such  as  Lactobacillus
G  and  Biﬁdobacterium  breve  can  stimulate  the  process
f  immunological  tolerance  through  interleukin-production
timulation.1,22,23
The  M  cells  located  next  to  Peyer’s  patches  are  respon-
ible  for  the  presentation  of  intestinal  lumen  contents  and
hus,  stimulate  the  immunological  system  of  the  mucosa.1
Abnormalities  in  oral  tolerance  development  in  the  ﬁrst
onths  of  life  can  cause  non-IgE-mediated  allergy  to  cow’s
ilk  protein.24
astrointestinal  signs  and  symptoms  in  infants
he  occurrence  of  digestive  symptoms  is  common  in  the  ﬁrst
onths  of  life,  such  as  regurgitation,  vomiting,  colic,  and
onstipation.  Some  clinical  manifestations,  although  they
o  not  constitute  a  deﬁned  disease,  may  be  of  concern
o  parents,  such  as  ﬂatulence,  which,  incidentally,  is  hard
o  quantify  to  be  characterized  as  excessive  or  not.  Many
f  these  symptoms  may  be  transient  and  are  attributed  to
mmaturity  and/or  are  considered  as  part  of  the  develop-
ent  of  the  gastrointestinal  tract.  Many  of  these  clinical
anifestations  are  included  in  functional  gastrointestinal
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o50  
isorders  and  their  diagnosis  can  be  established  by  the  Rome
II  criteria.25 The  gastroesophageal  reﬂux  disease  (GERD)
nd  allergy  to  cow’s  milk  protein  are  not  functional  gas-
rointestinal  disorders;  however,  they  can  lead  to  several
astrointestinal  signs  and  symptoms,  especially  in  the  ﬁrst
ear  of  life.26,27 In  pediatric  practice,  allergy  to  cow’s  milk
rotein  and  GERD  are  often  part  of  the  differential  diagnosis
f  gastrointestinal  functional  disorders.28,29
Therefore,  the  infant  can  have  different  gastrointestinal
igns  and  symptoms,  especially  in  the  ﬁrst  six  months  of  life.
he  physician  should  recognize  the  clinical  manifestation
s  isolated  and/or  transient  or  as  part  of  a  functional  gas-
rointestinal  disorder,  allergy  to  cow’s  milk,  or  even  GERD.
ther  diseases  that  are  not  restricted  to  the  digestive  tract
re  included  in  the  differential  diagnosis.  Only  after  careful
valuation  and  deﬁnition  of  the  diagnostic  hypothesis  it  is
ossible  to  deﬁne  the  approach  to  be  used.  Table  2  presents
nformation  that  can  contribute  to  the  differential  diagno-
is  of  gastrointestinal  signs  and  symptoms  in  infants.25--32
yclic  vomiting  syndrome  and  rumination  were  not  included,
ecause  they  are  not  as  prevalent  as  other  functional  gas-
rointestinal  disorders.
In  2015,  a  group  of  specialists  from  several  countries
valuated  the  available  information  in  the  literature  on
he  prevalence  of  gastrointestinal  functional  disorders  in
he  ﬁrst  year  of  life.5 The  median  prevalence  of  infantile
olic  in  30  articles  was  18%;  however,  great  variability  was
bserved  due,  at  least  in  part,  to  the  diversity  of  diagnostic
riteria.  It  is  interesting  to  mention  that,  in  a  study  con-
ucted  in  Brazil  that  characterized  infantile  colic  according
o  the  Wessel  criterion,  16%  of  the  1086  infants  assessed
ad  colic;  however,  according  to  their  mothers,  80%  had
olic.33 Therefore,  there  is  no  full  consensus  among  the
ifferent  diagnostic  criteria  used  in  the  studies  of  preva-
ence,  as  well  as  the  opinions  and  expectations  of  parents.
egarding  the  prevalence  of  infant  regurgitation,  13  arti-
les  were  retrieved,  with  results  ranging  from  3%  to  87%.
he  Rome  III  criteria  was  used  in  only  two  of  these  13
rticles  (two  or  more  regurgitations  a  day  for  more  than
hree  weeks),  with  a  prevalence  of  17%  and  26%.  It  should
e  noted  that,  in  general,  infant  regurgitation  disappears
pontaneously  up  to  12  months  of  life.5,34,35 In  turn,  the
revalence  of  GERD  in  infants  is  unknown,  but  it  is  accepted
hat  it  is  much  lower  than  that  of  infant  regurgitation.35
he  prevalence  of  functional  constipation  in  the  ﬁrst  year
f  life  showed  great  variation,  from  less  than  1%  to  39%  in
he  eight  studies  retrieved.5 Two  cross-sectional  studies  that
sed  the  Rome  III  criteria  found  a  prevalence  of  constipation
f  0.05--5%.5 In  the  author’s  opinion,  the  Rome  III  criteria
nderestimate  the  diagnosis  of  intestinal  constipation,  espe-
ially  in  the  ﬁrst  year  of  life.36,37 A  recent  study  compared
he  prevalence  of  intestinal  constipation  in  831  Brazilian
nfants  using  the  Rome  III  criteria  and  another  broader  crite-
ion  (elimination  of  hard  stools  with  pain/difﬁculty  and/or
ess  frequently  than  three  times  a  week;  or  elimination  of
ylindrical  hard  stools  with  cracks  or  scybalous  stools,  even
f  eliminated  without  pain  or  difﬁculty).38 According  to  the
ome  III  criteria,  the  prevalence  of  intestinal  constipation
as  1.1%,  whereas  the  broader  criterion  identiﬁed  consti-
ation  in  19.6%  of  the  study  population.38
It  is  estimated  that  the  prevalence  of  allergy  to  cow’s
ilk  protein  ranges  from  2%  to  3%  in  the  ﬁrst  year  of  life.27
i
a
f
AMorais  MB
t  must  be  remembered,  however,  that  clinical  manifesta-
ions  suggestive  of  allergy  to  cow’s  milk  are  present  in  a
igher  percentage  of  infants,  approximately  9%  according
o  a  prospective  study  carried  out  in  the  Netherlands.39 It
an  be  estimated  that  only  a  portion  of  infants  (approxi-
ately  30--50%)  that  undergo  an  elimination  diet  will  show
 positive  challenge  test,  conﬁrming  the  diagnosis.39,40
Thus,  it  can  be  observed  that  many  infants  have  gastroin-
estinal  signs  and  symptoms.  Some  of  these  infants  have
ore  than  one  symptom.4,41 These  gastrointestinal  manifes-
ations  are  often  reasons  for  changes  in  the  infants’  diet,
ainly  changes  in  the  type  of  infant  formula.42,43
ediatric  care  for  infants  with  gastrointestinal
linical  manifestations
he  ﬁrst  point  to  be  considered  is  whether  the  infant’s  gas-
rointestinal  sign  or  symptom  is  actually  part  of  a  disease
r  simply  part  of  the  normal  digestive  physiology  or  of  the
evelopment  of  the  gastrointestinal  tract  in  the  ﬁrst  year  of
ife.
During  pediatric  visits,  parents  often  mention  that  their
hildren  pass  an  excessive  volume  of  gas.  An  article  with
uggestions  of  conduct  for  frequent  gastrointestinal  signs
n  infants  discusses  this  question,  associating  it  with  cry-
ng  and  fussiness.3 It  is  noteworthy  that  the  presence  of  gas
n  the  digestive  tract  is  normal.  Excess  gas,  however,  could
esult  from  an  inappropriate  breastfeeding  technique,  with
he  occurrence  of  aerophagia.3
Excessive  crying  and  fussiness  are  often  considered  as
astrointestinal  manifestations.44,45 In  1954,  Wessel  deﬁned
nfantile  colic  as  episodes  of  irritability,  agitation,  or  intense
rying  for  at  least  three  hours,  three  days  a  week  and  last-
ng  more  than  three  weeks  (‘‘rule  of  three’’).46 In  general,
t  disappears  at  approximately  four  months  of  life.44,45 In
006,  infantile  colic  was  included  in  the  Rome  III  crite-
ia  (Table  2),  which  aims  to  standardize  the  diagnosis  of
unctional  gastrointestinal  disorders.25 In  practice,  both
or  health  professionals  and  parents,  these  criteria  do  not
lways  have  to  be  fully  met  for  infantile  colic  to  be  consid-
red  a  concern  and  a  serious  problem.
A  study  conducted  in  the  pediatric  emergency  depart-
ent  of  the  Netherlands  has  shown  that,  in  the  care  of
nfants  with  crying  as  the  main  cause  of  consultation,
pproximately  6%  of  parents  acknowledged  the  practice  of
ctions  that  could  pose  a  serious  health  hazard  to  infants,
uch  as  shaking  (which  can  be  a  cause  of  the  ‘‘shaken  baby
yndrome’’)  and  attempts  at  suffocation.47 Alarming  results
ere  found  in  another  study  carried  out  in  Japan.48
Mothers  of  infants  with  colic  may  have  decreased  quality
f  life,  especially  in  the  areas  of  physical  and  social  per-
ormance,  and  increased  risk  of  depression,49,50 which  may
ecrease  with  the  control  of  colic.51 Thus,  infantile  colic,
xpressed  as  intense  and  inconsolable  crying,  constitutes  an
mportant  health  problem  in  the  ﬁrst  four  months  of  life.
n  addition  to  the  infant’s  suffering,  it  can  be  the  cause
f  a  great  deal  of  anxiety  in  parents  and  reduce  the  fam-
ly’s  quality  of  life.49 It  should  be  emphasized  that  pediatric
ssessment  of  crying  infants  should  be  detailed  and  care-
ul,  aiming  to  identify  causes  that  require  speciﬁc  therapy.
 retrospective  study  conducted  in  Toronto  highlights  the
Digestive  signs  and  symptoms  in  infants  S51
Table  2  Diagnostic  criteria  for  infant  diseases  presenting  with  predominantly  gastrointestinal  symptoms.
1.  Infantile  colic  Rome  III  Criteria  (2006):25 all  of  the  following  characteristics  from  birth  to  4
months of  age:  1.  episodes  of  paroxysms  of  irritability,  fussing,  or  crying  that
starts and  stops  without  obvious  causes;  2.  episodes  lasting  three  or  more
hours/day  for  three  days/week  for  at  least  one  week;  no  failure  to  thrive.
2. Infant  regurgitation
(‘‘physiological  reﬂux’’)
Rome  III  Criteria  (2006):25 All  of  the  following  characteristics  in  otherwise  healthy
infants:  1.  two  or  more  regurgitations  per  day  for  three  or  more  weeks;  no
retching,  hematemesis,  aspiration,  apnea,  failure  to  thrive,  feeding  or
swallowing  difﬁculties,  or  abnormal  posture.
3. Functional  intestinal
constipation
Rome  III  Criteria  (2006)25 and  ESPGHAN/NASPGHAN  guideline  (2014):30 duration
of at  least  on  month  of  two  or  more  of  the  following  characteristics:  1.  fewer
than three  bowel  movements  a  week;  2.  at  least  one  weekly  episode  of  fecal
incontinence  after  sphincter  control;  3.  history  of  excessive  retention  of  feces;  4.
history of  pain  and/or  difﬁculty  in  bowel  movements;  5.  presence  of  large  fecal
mass in  the  rectum;  6.  history  of  elimination  of  large-diameter  feces  that  can
clog the  toilet.  Additional  symptoms:  irritability,  decreased  appetite,  and  early
satiety.  These  symptoms  disappear  after  elimination  of  large  amounts  of  feces.
4. Functional  diarrhea
(‘‘irritable  bowel
syndrome’’)
Rome  III  Criteria  (2006):25 all  of  the  following  characteristics:  1.  daily  painless,
recurrent  passage  of  three  or  more  large,  unformed  stools;  2.  duration  longer
than 4  weeks;  3.  onset  between  6  and  36  months  of  age;  4.  passage  of  stools
during waking  hours;  5.  No  failure  to  thrive  if  caloric  intake  is  adequate.
5. Infantile  dyschezia Roma  III  Criteria  (2006):25 It  should  include  the  two  following  characteristics  in
infants younger  than  6  months:  1.  at  least  10  min  of  straining  and  crying  before
successful  passage  of  soft  stools;  2.  no  other  health  problems.
6. Gastroesophageal  reﬂux
disease  (GERD)
NASPGHAN/ESPGHAN  Guideline  (2009):26 It  is  present  when  gastroesophageal
reﬂux  causes  symptoms  that  are  uncomfortable  and/or  complications.  Clinical
manifestations  suggestive  of  GERD  before  18  months:  recurrent  regurgitations
and/or  vomiting  accompanied  by  failure  to  thrive;  stressed  behavior  or  crying
without  explanation.
7. Allergy  to  cow’s  milk  protein  Brazilian  Consensus  (2007)31 and  ESPGHAN  Guideline  (2012):27 adverse  reaction,
reproducible,  caused  by  an  immune  reaction  triggered  by  antigen(s)  of  certain
food(s).  In  infants,  it  is  often  a  delayed  reaction  (non-IgE-mediated).  In  a  group
of 159  infants  with  suspected  allergy  to  cow’s  milk  protein,  the  following
gastrointestinal  signs  and  symptoms  were  found  (each  infant  could  have  more
than one  clinical  manifestation):  regurgitation  and  vomiting  in  53.5%;  colic  in
34.0%; diarrhea  in  25.2%,  of  which  approximately  30%  with  blood;  blood  in  the
stool in  14.5%;  and  constipation  in  15.7%.  Weight  and  length  deﬁcit  were
commonly  observed.32
In  most  cases,  the  diagnosis  must  be  conﬁrmed  by  challenge  test  with  the
suspected  food,  to  be  performed  four  to  12  weeks  after  the  start  of  the
elimination  diet  when  the  symptoms  have  already  been  controlled.27,31
Infantile colic, infantile regurgitation, constipation, functional diarrhea, and infantile dyschezia are included among the gastrointestinal
functional disorders and the Rome III criteria may be used for the diagnosis (see comments in the text). Gastroesophageal reﬂux disease
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infants and have events that are similar to gastrointestinal functi
importance  of  clinical  history,  physical  examination,  and
urinalysis  in  the  evaluation  of  febrile  infants  with  crying,
irritability,  and  fussiness.52 It  is  important  to  remember  that
infantile  colic  occurs  equally  in  the  presence  of  natural  and
artiﬁcial  feeding.44,45
In  general,  regurgitation  as  an  isolated  manifestation
in  infants  reﬂects  the  occurrence  of  physiological  reﬂux
(infant  regurgitation  according  to  the  Rome  III  criteria,
Table  2).  In  GERD  other  signs  are  observed  associated  with
regurgitation  and  vomiting,  including  weight  gain  deﬁcit
and  clinical  manifestations  attributed  to  probable  reﬂux
esophagitis,  such  as  irritability,  excessive  crying,  and  dif-
ﬁculty  feeding.26,34,35 The  diagnosis  of  GERD  is  essentially
clinical.  Infants  with  mild  symptoms  and  no  warning  signs
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ty are prevalent causes of gastrointestinal signs and symptoms in
isorders.
re  called  ‘‘happy  vomiters’’  and  there  is  no  need  for
edication.34
There  are  questionnaires  developed  to  help  differentiate
etween  infantile  regurgitation  and  GERD.  In  the  analysis
f  a  questionnaire  for  this  purpose,  the  clinical  evalua-
ion  by  an  experienced  specialist  was  used  as  reference,
upplemented  or  not  with  other  exams.53 Ultrasonography
as  no  value  in  differentiating  infantile  regurgitation  from
ERD26,34,35 and  thus,  it  should  not  be  indicated  for  assess-
ent  of  the  infant  with  suspected  GERD.  It  is  very  useful
hen  there  is  suspicion  of  hypertrophic  pyloric  stenosis.
ontrast  radiography  of  the  esophagus,  stomach,  and  duo-
enum  may  be  indicated  when  anatomical  abnormalities  of
he  upper  gastrointestinal  tract  are  suspected.26,34,35
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Two  articles  have  been  recently  published  on  the  practice
f  Brazilian  pediatricians  regarding  the  evaluation  of  infants
ith  excessive  crying  or  suspected  GERD.54,55 In  the  ﬁrst
tudy,  132  pediatricians  were  asked  to  analyze  a  case  of
n  exclusively  breastfed  infant  with  excessive  crying,  regur-
itation,  and  fully  satisfactory  weight  gain.  The  diagnostic
ypothesis  of  GERD  was  suggested  by  63%  of  respondents,
hile  24%  considered  the  possibility  of  infantile  colic.54 This
esult  suggests  that  there  is  an  overestimation  of  the  pos-
ibility  of  GERD  in  the  clinical  context.  The  second  study
nvolved  140  professionals  who  analyzed  two  typical  clinical
ases,  one  of  infantile  regurgitation  (physiological  reﬂux)
nd  another  with  GERD.53 Based  on  the  answers  about  the
pproach  to  be  adopted,  the  authors  concluded  that  most
ediatricians  correctly  differentiated  physiological  reﬂux
rom  GERD.55
Regarding  the  intestinal  habits,  it  should  be  noted  that,
n  general,  the  passage  of  ﬁrst  meconium  occurs  within  the
rst  24  h  of  life.  Preterm  newborns  with  less  than  1500  g  of
irth  weight  may  have  the  passage  of  ﬁrst  meconium  after
8  h.56
There  are  few  studies  in  the  literature  that  evaluated
ntestinal  habits  of  infants.56--62 Considering  the  information
n  these  articles,  it  can  be  said  that,  in  the  ﬁrst  month  of
ife,  most  infants  have  four  to  six  bowel  movements  a  day.
his  number  decreases  after  the  second  month  of  life.  The
umber  of  stools  and  stool  consistency  is  associated  with  the
ype  of  feeding.  It  is  well  established  that  breastfed  infants
ave  more  bowel  movements  when  compared  with  formula-
ed  infants.58,60 The  stool  of  breastfed  infants  is  softer  than
hose  who  receive  infant  formula.56,58 The  type  of  infant
ormula  can  also  inﬂuence  the  consistency  of  stools  and  stool
requency.  Infants  fed  conventional  or  soy  infant  formula
ad  half  the  frequency  of  bowel  movements  and  harder  stool
onsistency  compared  to  breastfed  infants.63 In  comparison,
hose  receiving  extensively  hydrolyzed  protein  formula  have
n  increased  frequency  of  bowel  movements  and  softer  stool
onsistency.63
The  main  changes  in  the  infant’s  intestinal  habits  are
iarrhea  and  constipation.  Generally,  diarrhea  is  deﬁned  as
he  occurrence  of  three  or  more  loose  stools  in  the  preceding
4  h.64,65 It  is  a  broad  deﬁnition  that  includes  bacterial  and
iral  infections  of  the  digestive  tract  (acute  and  persistent
iarrhea),  which  can  cause  dehydration  and  malnutrition,
nd  are  not  included  in  the  scope  of  this  article.  Nonethe-
ess,  it  is  worth  mentioning  that  some  parents  mistakenly
onsider  the  frequency  and  consistency  of  stools  in  the  ﬁrst
onth  of  life  as  ‘‘diarrhea’’,  which  actually  constitutes  nor-
al  bowel  habits.  Conversely,  intestinal  constipation  usually
tarts  with  the  elimination  of  hard,  scybalous  stools,  with
ain  or  difﬁculty.66 However,  the  Rome  III  criteria25 does
ot  take  into  account  the  shape  and  consistency  of  stools
o  characterize  intestinal  constipation  in  infants,  which  can
elay  the  diagnosis.
rinciples  and  perspectives  for  the  control  of
astrointestinal  signs  and  symptoms  in  infantsor  infants  with  colic  and  regurgitation,  the  most  important
rocedure  is  elucidating  parents  about  the  benign  and  tran-
itory  characteristic  of  these  manifestations.3,4,26,34,44,45 In
o
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his  context,  parents  should  be  sure  that  additional  exams
re  not  required  and  that  their  children  are  not  at  immediate
r  future  risks.  It  is  advisable  to  check  the  sources  that  par-
nts  are  possibly  accessing  to  obtain  information  about  the
ealth  of  their  children  and,  when  necessary,  appropriate
nd  corrective  pediatric  guidelines  should  be  offered.
It  is  important  to  avoid  prescribing  unnecessary  medi-
ations.  A  common  approach  is  to  conduct  unjustiﬁed  and
ften  prolonged  empiric  treatment  for  probable  esophagi-
is  due  to  gastroesophageal  reﬂux  in  infants  with  excessive
rying  and  irritability.
In  this  context,  it  is  important  to  mention  the  abusive
se  of  proton-pump  inhibitors  in  infants.67 According  to  clin-
cal  trials68,69 and  a  meta-analysis,70 proton-pump  inhibitors
rovide  no  reduction  in  the  daily  duration  of  infantile  cry-
ng  and  can  also  cause  adverse  affects.67 A  study  carried  out
n  Brazil  showed  that  prokinetics,  such  as  domperidone  and
romopride,  are  considered  in  the  treatment  of  infants  with
nfantile  regurgitation  and  GERD,55 which  goes  against  the
ost  recent  recommendations.26,34,35
A  study  carried  out  in  11  European  countries71
ith  567  pediatricians  showed  that  few  follow  the
ASPGHAN/ESPGHAN  (North  American  Society  for  Pedi-
tric  Gastroenterology,  Hepatology  and  Nutrition/European
ociety  for  Pediatric  Gastroenterology,  Hepatology,  and
utrition)  guideline,  published  in  2009.26 The  reasons  for
he  lack  of  adherence  to  the  care  protocols  should  be  the
ubject  of  future  studies.  It  should  be  noted  that  there  is  no
vidence  that  dimethicone  is  effective  in  the  treatment  of
nfantile  colic.44,45
Regarding  the  feeding  regimen,  exclusive  breastfeed-
ng  should  always  be  maintained.  No  gastrointestinal  signs
r  symptoms  should  be  understood  as  reason  for  breast-
eeding  interruption,  as  shown  in  the  reviews34,44,45 and
uidelines26,27,30,31,35,36 for  the  treatment  of  gastrointestinal
unctional  disorders.
Regarding  infants  with  suspected  allergy  to  cow’s  milk
hile  receiving  exclusive  breastfeeding,  the  mother  should
liminate  cow’s  milk  proteins  from  her  diet.27,31 Infants  with
ood  allergies  during  breastfeeding  and  with  severe  clin-
cal  manifestations,  with  stunting  and/or  iron  deﬁciency
nemia,  for  instance,  should  be  individually  assessed  by  spe-
ialists.  Specialized  assessment  should  also  be  carried  out
n  infants  with  suspected  disease  such  as  galactosemia  and
ongenital  glucose--galactose  malabsorption,  among  others.
For  infants  who  no  longer  receive  breast  milk  and  when
elactation  cannot  be  achieved,  there  are  several  formu-
as  that  have  been  developed  to  contribute  for  the  control
f  gastrointestinal  signs  and  symptoms  in  infants,  including:
.  thickened  formulas,  2.  soy  formulas,  3.  formulas  with
artially  hydrolyzed  proteins  and  lower  lactose  content,
.  formulas  with  prebiotics,  5.  formulas  with  extensively
ydrolyzed  proteins,  with  and  without  lactose,  and  6.  amino
cid  formulas.
Thickened  formulas  provide  a  decrease  in  the  frequency
nd  volume  of  regurgitation.  Thus,  they  can  decrease  the
arents’  anxiety.  It  should  be  noted  that  they  are  formulas
hat  reduce  regurgitation,  but  not  the  total  time  of  exposure
f  the  esophagus  to  gastric  acid.26,34,35
Another  situation  that  constitutes  a  major  healthcare
roblem  is  that  of  infants  with  regurgitation,  vomiting,
rritability,  and  excessive  crying,  associated  or  not  with
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other  clinical  manifestations.  Diagnostic  hypotheses  of  GERD
and  allergy  to  cow’s  milk  protein  are  often  considered.
The  ESPGHAN/NASPGHAN  guideline  for  infants  with  fre-
quent  regurgitation  and  irritability,  associated  or  not  with
decreased  weight  gain,  recommends  the  exclusion  of  cow’s
milk  protein  from  the  diet  for  two  to  four  weeks.26 The
guideline  suggests  formulas  with  extensively  hydrolyzed  pro-
teins  or  amino  acid  formulas  as  substitutes.26 Thus,  in  case  of
patient  improvement  after  this  period  of  elimination  diet,  a
challenge  test  should  be  planned  to  conﬁrm  the  diagnosis.27
However,  many  physicians  that  recommend  cow’s  milk  elim-
ination  from  the  diet  do  not  perform  the  challenge  test  to
ascertain  the  diagnosis  of  allergy  to  cow’s  milk.72,73 This
procedure  maintains  a  substantial  proportion  of  infants39,40
that  are  not  allergic  to  cow’s  milk  (but  who  casually  had  a
reduction  in  clinical  manifestations)  on  a  replacement  diet,
which  is  more  expensive,  for  a  period  longer  than  necessary.
Although  not  indicated  for  infants  younger  than  six  months,
about  one-third  of  pediatricians  would  prescribe  soy  formula
to  infants  with  suspected  gastroesophageal  reﬂux  secondary
to  allergy  to  cow’s  milk  protein.55 It  should  be  noted  that
soy  formulas  are  not  indicated  for  the  treatment  of  infan-
tile  colic,3,4,44,45 allergy  to  cow’s  milk  protein  in  the  ﬁrst  six
months  of  life,27,31 infant  regurgitation,  or  GERD.26,34,35
Formulas  with  partially  hydrolyzed  proteins  and  low  lac-
tose  content  have  been  used  in  infants  with  gastrointestinal
manifestations  such  as  colic,  regurgitation,  ﬂatulence,  and
hardened  stools,  based  on  open  clinical  trials.74--77 It  can
be  hypothesized  that  their  effectiveness  in  these  circum-
stances  is  related  to  the  following  mechanisms:  1.  increased
rate  of  gastric  emptying78,79 and  2.  decrease  in  the  effects
of  excessive  fermentation  of  carbohydrates  in  the  intestinal
lumen,  considering  that  in  patients  with  infantile  colic,  a
greater  production  of  hydrogen  in  the  expired  air  has  been
demonstrated  in  the  hydrogen  breath  test.80--82 It  should  be
noted  that  no  formula  with  partially  hydrolyzed  proteins,
with  normal  or  low  content  of  lactose,  should  be  used  in  the
treatment  of  infants  with  suspected  allergy  to  cow’s  milk
protein.77
Breastfed  infants  have  low  risk  for  constipation.  This  may
be  a  consequence  of  the  oligosaccharide  content  in  human
milk,  which  increases  the  frequency  of  bowel  movements
and  decreases  stool  consistency.83 Several  mechanisms  may
account  for  this  effect:81 1.  increased  microbial  mass
(including  probiotic  bacteria)  due  to  the  availability  of
oligosaccharides  to  be  fermented;  2.  selective  growth  of
Biﬁdobacterium  and  Lactobacillus  bacteria  that  ferment  the
oligosaccharides  and  produce  short-chain  fatty  acids  that
increase  the  water  content  in  the  stool.83 In  turn,  the  short-
chain  fatty  acids  can  stimulate  intestinal  motility,  as  they
are  used  as  an  energy  source  by  colonocytes  and  induce  tonic
and  phasic  contractions  in  the  circular  muscles  of  the  colon;
and  3.  oligosaccharides  play  the  role  of  soluble  ﬁbers  and,
thus,  increase  the  water  content  of  the  stool.83
The  same  effect  on  intestinal  habit  and  stool  consistency
can  be  obtained  by  adding  prebiotics  to  infant  formula.84--87
Thus,  more  frequent  bowel  movements  with  softer  consis-
tency  can  be  obtained  with  the  use  of  infant  formula  with
added  prebiotic,  which  can  potentially  reduce  the  likelihood
of  constipation  onset.  The  NASPGHAN/ESPGHAN  guideline
offers  a  speciﬁc  algorithm  for  constipation  before  six  months
of  age.30S53
Probiotics  are  live  microorganisms  that,  when  consumed
n  adequate  amounts,  provide  a  beneﬁcial  effect  to  the
ost’s  health.88,89 Infants  with  colic90 or  allergy  to  cow’s
ilk  protein91 may  show  alterations  in  the  intestinal  micro-
iota,  as  observed  in  functional  gastrointestinal  disorders
nd  other  allergic  diseases.92 Thus,  the  role  of  probiotics  in
ontrolling  these  diseases  in  infants  has  been  the  subject  of
everal  studies.
Clinical  trials51,93--95 and  a  meta-analysis96 showed  that
actobacillus  reuteri  DSM  17938  provides  a  reduction  in  daily
rying  time  in  patients  with  infantile  colic.  In  turn,  Lacto-
acillus  GG  can  accelerate  the  acquisition  of  tolerance  by
nfants  with  allergy  to  cow’s  milk  protein.22,23 From  a  clin-
cal  point  of  view,  it  is  important  to  emphasize  that  the
ffect  of  a particular  probiotic  is  speciﬁc  to  a  particular
train.  A  clinical  trial  showed  that  administration  of  Lac-
obacillus  reuteri  DSM  17938  can  reduce  the  frequency  of
astrointestinal  symptoms  in  the  ﬁrst  months  of  life.97 These
ata  show  how  the  development  of  research  in  the  ﬁeld  of
rebiotics  and  probiotics  for  the  prevention  and  control  of
astrointestinal  signs  and  symptoms  in  infants  is  promising.
In  conclusion,  the  prevalence  of  gastrointestinal  signs  and
ymptoms  in  infants  is  very  high.  The  diagnosis  is  usually
ased  on  information  from  parents  and  the  clinical  exami-
ation  of  the  child,  including  weight  assessment.  The  lack  of
peciﬁc  and  precise  tests  may  hinder  the  differential  diag-
osis.  Offering  recommendations  and  support  to  parents  is
rucial,  regardless  of  the  diagnosis.  Exclusive  breastfeeding
hould  always  be  stimulated  and  maintained.
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